Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Equipment
  3. usa washington
  4. targeted boron drugs
Show results for
Products

Companies


Refine by
Locations
Back to All Locations

  • USA
  • Washington
Brands

  • sengine
  • zymeworks
Applications

  • Solution for Clinical Trials
  • Solution for Access to Investigational Medicines

Targeted Boron Drugs Equipment Supplied In Usa Washington

3 equipment items found
In WashingtonAvailable In WashingtonNear Washington

Zymeworks - Model ZW49 - Bispecific Antibody Drug Conjugate (ADC)

Zymeworks - Model ZW49 - Bispecific Antibody Drug Conjugate (ADC)

by:Zymeworks Inc   based inVancouver, BRITISH COLUMBIA (CANADA)
ZW49 is a HER2-targeted antibody drug conjugate (ADC) developed using Zymeworks’ proprietary Azymetric™ and ZymeLink™ platforms. ZW49 is currently being evaluated in a Phase 1 clinical trial as a treatment for patients with locally advanced or metastatic HER2-expressing cancers that have progressed following treatment with existing approved therapies, including HER2-targeted ...
CONTACT SUPPLIER

SEngine - Guiding Drug Discovery Technology

SEngine - Guiding Drug Discovery Technology

Manufactured by:SEngine Precision Medicine   based inSeattle, WASHINGTON (USA)
Guiding drug discovery with proprietary high throughput 3D patient cell technology and genomics will drastically increase the success of novel drug candidates and directly result in faster development at reduced costs. SEngine Precision Medicine’s innovative approach brings diagnostics, drug discovery and proprietary algorithms together with our patient-derived 3D tumor organoids to ...
CONTACT SUPPLIER

Model CTT1403 - PSMA-targeted 177Lu-Labeled Agent for Prostate Cancer

Model CTT1403 - PSMA-targeted 177Lu-Labeled Agent for Prostate Cancer

Manufactured by:Cancer Targeted Technology   based inWoodinville, WASHINGTON (USA)
CTT’s lead therapeutic product, CTT1403, is a PSMA-targeted 177Lu-labeled agent for prostate cancer that can has superior binding characteristics, long circulation half-life, enhanced tumor uptake and unparalleled anti-tumor efficacy. CTT1403 will specifically deliver the radionuclide, 177Lu, minimizing toxic side effects and more effectively treating metastatic prostate cancer and other ...
CONTACT SUPPLIER
  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT